Scale-up companies that are ready for the next growth phase and are looking for investors and partners to achieve that, will present themselves in this session. Join this session and find out what impact the following companies aim to make for healthcare and how you can partner with them in that journey.
The deadline for application has passed and the selection has been made. The following pitches have been accepted for a presentation:
Euretos AI Platform
You can find more information on these companies below.
Elise Meijer AMS & Accenture Moderator
Euretos AI Platform Arie Baak, Co-founder AI & translational systems biology driven validation and discovery of targets, biomarkers & indications
MAT Biotech Henk Vietor, CEO Oh no, another hurdle in development
Orikami Bert Seegers, Chief Business Officer Digital Biomarkers to improve Quality of Life and manage healthcare cost.
OcellO Leo Price, CEO In vitro organoid services for Selecting, Characterising and de-risking pre-clinical compounds
Rejuvenate Biomed Ann Belien, CEO Healthy aging and sarcopenia: IP protected repurposed prescription drugs
LIPOZYT MARKER Wolfgang Hierneis, Strategy & Finance A new dimension in precision diagnostics - mRNA and AI
GENOMTEC Miron Tokarski, CEO Genomtec - genetic testing laboratory that fits in your pocket
The audience picked Healthy Mind, Iova and PharmaCytics as their top 3 pitchers and of these the jury chose PharmaCytics as the winner of the Axon Innovation for Health Award.